Liminal BioSciences Inc.

NASDAQ: LMNL · Real-Time Price · USD
8.50
0.01 (0.12%)
At close: Sep 25, 2023, 9:59 PM

Liminal BioSciences Revenue

Liminal BioSciences reported an annual revenue of $401K, reflecting a -37.64% growth. For the quarter ending June 30, 2023, Liminal BioSciences generated $112K in revenue.
Revenue (ttm)
401K
Revenue Growth
-37.64%
Price / Sales Ratio
0.93
Revenue / Employee
1.6K
Employees
251
Market Cap
27.62M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2022 401K -37.64%
Dec 31, 2021 643K -80.62%
Dec 31, 2020 3.32M -32.36%
Dec 31, 2019 4.9M -89.65%
Dec 31, 2018 47.37M +21.11%
Dec 31, 2017 39.12M +138.62%
Dec 31, 2016 16.39M -33.19%
Dec 31, 2015 24.53M +6.62%
Dec 31, 2014 23.01M +11.46%
Dec 31, 2013 20.64M -11.48%
Dec 31, 2012 23.32M +32.59%
Dec 31, 2011 17.59M +53.84%
Dec 31, 2010 11.43M -15.69%
Dec 31, 2009 13.56M +33.54%
Dec 31, 2008 10.15M +20.37%
Dec 31, 2007 8.44M +218.70%
Dec 31, 2006 2.65M -67.13%
Dec 31, 2005 8.05M -1.60%
Dec 31, 2004 8.18M +520.21%
Dec 31, 2003 1.32M -47.47%
Dec 31, 2002 2.51M +0.43%
Dec 31, 2001 2.5M +20.27%
Dec 31, 2000 2.08M -30.69%
Dec 31, 1999 3M -70.00%
Dec 31, 1998 10M +376.19%
Sep 30, 1997 2.1M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.